WiseGuyReports.Com Publish a New Market Research Report On –“ Anti Asthma Drugs 2019 Global Market to Reach US$ 28.3 billion and Growing at CAGR of 5.94% by 2023”.
Anti Asthma Drugs Industry 2019
This report analyzes the global anti-asthma drugs market by type of asthma (allergic (extrinsic) and non-allergic (intrinsic) asthma), by asthma trigger type (child-onset asthma, adult-onset asthma, exercise-induced asthma, cough-induced asthma, occupational asthma, nocturnal asthma, steroid-resistant asthma (severe asthma)), by drug class (bronchodilators (beta agonists, anti-cholinergics, xanthines), leukotriene antagonists, mast cell stabilizers, corticosteroids, monoclonal antibody), by therapy (reliever treatment and maintenance treatment) and by route of administration (oral, inhaled, intravenous, subcutaneous); it also studies the top manufacturers in the market.
For more information or any query mail at firstname.lastname@example.org
The global anti-asthma drugs market was valued at USD 18.9 billion as of 2015 and is projected to reach USD 28.3 billion as of 2022, at a CAGR of 5.94%.
The major players in global anti-asthma drugs market include:
- GlaxoSmithKline plc.
• Merck & Co., Inc.
• AstraZeneca plc.
• F. Hoffmann-La Roche Ltd
• Teva Pharmaceutical Industries
• Novartis International AG
• Boehringer Ingelheim
• Sunovion Pharmaceuticals Inc.
The market revenue and share have been analyzed with respect to the following regions and countries:
Rest of Europe
Republic of Korea
Rest of Asia Pacific
Middle East & Africa
On the basis of type of asthma, the global anti-asthma drugs market has been categorized into the following segments:
- Allergic (extrinsic)
• Non-allergic (intrinsic) asthma
On the basis of asthma trigger type, the global anti-asthma drugs market has been categorized into the following segments:
- Child-onset asthma
• Adult-onset asthma
• Exercise-induced asthma
• Cough-induced asthma
• Occupational asthma
• Nocturnal asthma
• Steroid-resistant asthma (severe asthma)
On the basis of drug class, the global anti-asthma drugs market has been categorized into the following segments:
- Bronchodilators (beta agonists, anti-cholinergics, xanthines)
• Leukotriene antagonists
• Mast cell stabilizers
• Monoclonal antibody
On the basis of therapy, the global anti-asthma drugs market has been categorized into the following segments:
- Reliever treatment
• Maintenance treatment
On the basis of route of administration, the global anti-asthma drugs market has been categorized into the following segments:
Table Of Contents
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Anti-Asthma Drugs Market, By Type
6 Global Anti-Asthma Drugs Market, By Trigger
7 Global Anti-Asthma Drugs Market, By Drug Class
8 Global Anti-Asthma Drugs Market, By Therapy
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.